金石亚药
(300434)
| 流通市值：32.54亿 | | | 总市值：38.21亿 |
| 流通股本：3.42亿 | | | 总股本：4.02亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 491,653,780.52 | 291,494,123.06 | 1,102,354,866.43 | 756,645,811.15 |
| 营业收入 | 491,653,780.52 | 291,494,123.06 | 1,102,354,866.43 | 756,645,811.15 |
| 二、营业总成本 | 417,614,324.04 | 220,668,215.68 | 966,461,177.06 | 670,119,991.15 |
| 营业成本 | 211,950,118.37 | 115,818,296.44 | 469,213,169.76 | 337,593,894.03 |
| 税金及附加 | 9,626,983.05 | 5,155,483.77 | 21,571,892.35 | 13,289,533.3 |
| 销售费用 | 94,960,900.36 | 49,853,310.91 | 250,895,830.43 | 172,290,852.34 |
| 管理费用 | 78,008,243.13 | 39,415,502.92 | 179,246,441.41 | 118,903,992.75 |
| 研发费用 | 24,205,174 | 11,012,429.64 | 49,999,051.37 | 30,034,741.2 |
| 财务费用 | -1,137,094.87 | -586,808 | -4,465,208.26 | -1,993,022.47 |
| 其中:利息费用 | 668,900.8 | 290,322.69 | 1,319,956.2 | 1,008,743.17 |
| 其中:利息收入 | 1,832,525.58 | 803,388.87 | 5,338,914.99 | 3,366,004.22 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,920,944.45 | 1,417,319.45 | 2,998,847.22 | 1,625,273.55 |
| 加:投资收益 | -7,169,231.44 | -3,330,217.86 | -14,353,161.32 | -8,030,294.51 |
| 资产处置收益 | 45,291.39 | 44,491.19 | -20,095.66 | 6,163.41 |
| 资产减值损失(新) | -85,429.38 | 81,700.74 | -3,969,918.77 | -852,265.13 |
| 信用减值损失(新) | -1,756,002.13 | 1,170,657.79 | -4,270,494.2 | -3,167,062.79 |
| 其他收益 | 10,079,011.78 | 5,105,234.08 | 14,195,909.28 | 12,925,282.9 |
| 四、营业利润 | 78,074,041.15 | 75,315,092.77 | 130,474,775.92 | 89,032,917.43 |
| 加:营业外收入 | 46,531.87 | 35,608.34 | 1,738,845.96 | 1,159,656.93 |
| 减:营业外支出 | 727,173.41 | 281,320.59 | 9,557,083.94 | 7,495,058.72 |
| 五、利润总额 | 77,393,399.61 | 75,069,380.52 | 122,656,537.94 | 82,697,515.64 |
| 减:所得税费用 | 13,053,487.4 | 12,975,579.65 | 34,096,662.46 | 26,816,959.7 |
| 六、净利润 | 64,339,912.21 | 62,093,800.87 | 88,559,875.48 | 55,880,555.94 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 64,339,912.21 | 62,093,800.87 | 88,559,875.48 | 55,880,555.94 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 65,745,388.91 | 62,851,306.76 | 91,761,833.8 | 58,129,095.96 |
| 少数股东损益 | -1,405,476.7 | -757,505.89 | -3,201,958.32 | -2,248,540.02 |
| 扣除非经常损益后的净利润 | 55,723,013.69 | 57,730,277.27 | 82,294,435.98 | 52,041,443.82 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.16 | 0.16 | 0.23 | 0.14 |
| (二)稀释每股收益 | 0.16 | 0.16 | 0.23 | 0.14 |
| 九、综合收益总额 | 64,339,912.21 | 62,093,800.87 | 88,559,875.48 | 55,880,555.94 |
| 归属于母公司股东的综合收益总额 | 65,745,388.91 | 62,851,306.76 | 91,761,833.8 | 58,129,095.96 |
| 归属于少数股东的综合收益总额 | -1,405,476.7 | -757,505.89 | -3,201,958.32 | -2,248,540.02 |
| 公告日期 | 2025-08-28 | 2025-04-25 | 2025-04-25 | 2024-10-24 |
| 审计意见(境内) | | | 标准无保留意见 | |